纵横研报
Industry

特种化学品

12Reports
EMN.US logo
·特种化学品 ·内部研究

Eastman Chemical: A Cyclical Repair Story Already Priced for Stabilization

Eastman Chemical is a US specialty materials producer that has spent three decades shifting from a commodity chemical maker into a four-segment franchise, Advanced Materials, Additives & Functional Products, Chemical Intermediates, and Fibers, anchored by differentiated plastics, additives, and the Kingsport molecular-recycling platform. First-quarter 2026 revenue fell to $2.177 billion and adjusted EPS to $1.09 year over year, even as specialty volume rose more than 10 percent sequentially and 2026 capital spending is guided down to about $400 million from $546 million, improving cash conversion without requiring a demand recovery. Rating Hold: the portfolio's quality has genuinely improved and the shares yield near 5 percent, but auto, construction, and Chemical Intermediates weakness mean the current price already reflects the stabilization story, leaving little margin of safety.

Hold
SOLS.US logo
·特种化学品 ·内部研究

Solstice Advanced Materials: A Real Standalone Business, Not Enough Margin of Safety for the Deal

Solstice Advanced Materials is a recent Honeywell spin-off whose cash engine is refrigerants and applied solutions, now also building electronics materials and uranium-conversion businesses, and its first standalone year held up better than headline GAAP profit suggested. On July 6, 2026 the company agreed to acquire Element Solutions for about $14.5 billion in cash and stock, a deal that lifts net leverage from roughly 1.5x to 3.5x and dilutes existing holders to about 56% of the combined company, sending the stock from $82.80 down to $61.30. Rating Hold: the standalone business is genuinely solid, but today's price still does not offer enough margin of safety for both execution risk and deal risk at once.

Hold
·特种化学品 ·内部研究

Sika AG: Quality Compounder in a Cyclical Air Pocket

Sika is the global leader in construction chemicals (admixtures, waterproofing, sealants, roofing and industrial adhesives), selling locally adapted systems through more than 400 factories in over 100 countries, with bolt-on M&A such as Parex and MBCC built into its model. 2025 sales fell 4.8% to CHF 11.20bn on a strong Swiss franc and a soft construction cycle, yet local-currency growth stayed positive and material margin rose to 54.9% while MBCC synergies reached CHF 182m. Rating Hold: a first-rate serial-acquirer compounder caught in a cyclical air pocket, but at roughly 26x trailing earnings the valuation already prices much of the margin recovery before organic growth has returned.

Hold
VCT.LSE logo
·特种化学品 ·内部研究

Victrex(威格斯,VCT.LSE)横纵框架深度研究:全球 PEEK 之王跌去八成,好资产撞上结构性降价、中国建厂减值与一把悬着的减息刀

全球最大 PEEK(高性能工程塑料)制造商,做「以塑代金」的特种聚合物,卖给航空/医疗/电子/汽车;龙头地位 + 垂直一体化 + Invibio 植入级医疗(毛利约 75%)是真护城河。当前正撞上中国低价 PEEK(约进口半价)结构性重置定价——销量涨但利润降、底层营业利润率从 28% 腰斩到 16.5%。

观察
3402.TSE logo
·特种化学品 ·内部研究

东丽 (Toray) 长期所有者视角研究

巴菲特框架给「观察」。东丽 FY2026 收入约 2.585 万亿日元但 ROIC 仅 4.7%、ROE 4.5%;股价约 ¥1,160(P/B 0.94)看似低于净资产,保守 Owner Earnings 约 770 亿日元对应 22 倍并不便宜。合理买入价 ¥850–950,现价不满足安全边际。

观察